Portola Pharmaceuticals, Inc. Discovering and developing novel therapeutics.
Beskrivning av företaget:
portola pharmaceuticals is a biopharmaceutical company developing innovative drugs for the treatment of cardiovascular and inflammatory diseases portolaõs two most advanced programs are in phase ii clinical trials: 1) betrixaban, an oral, once-daily factor xa inhibitor being developed for stroke prevention in patients with atrial fibrillation (spaf) and for prevention of venous thromboembolism (vte) in various patient populations, and 2) elinogrel, a direct-acting, reversible oral and i.v. adp receptor antagonist initially being developed for patients with acute coronary syndrome (acs).
Sökord för att söka:
biopharmaceutical company, innovative drugs, treatment of cardiovascular diseases, inflammatory diseases, betrixaban, factor xa inhibitor, stroke prevention, atrial fibrillation, prevention of venous thromboembolism, elinogrel, oral and i.v. adp receptor antagonist, acute coronary syndrome, antithrombotic, thrombosis, inflammatory diseases
Företagets adress:
4941 Page Ave,MICHIGAN CENTER,MI,USA
Postnummer: Postal Code:
49254-1156
Telefonnummer :
5177640973 (+1-517-764-0973)
Faxnummer:
5177645554 (+1-517-764-5554)
hemsida:
www. portola. com
e-post:
USA SNI -kod ( Standard Industrial Classification Code) :
kopiera och klistra in den här google map på din webbplats eller blogg!
Tryck på Kopiera knappen och klistra in i din blogg eller hemsida.
(Gå över till " HTML "-läge när du postar in i din blogg. Examples: WordPress Example, Blogger Example)